Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screening.
Linda Hertlein, Christine Zeder-Göß, Sophie Fürst...
https://pubmed.ncbi.nlm.nih.gov/29623417Actively Recruiting
Led by Universiti Putra Malaysia · Updated on 2025-08-19
106
Participants Needed
1
Research Sites
N/A
Total Duration
This clinical trial focuses on women with gynecological cancer who are undergoing elective surgery. The study aims to compare the effects of perioperative immunonutrition supplements on nutritional, functional, and postoperative outcomes under an Enhanced Recovery After Surgery (ERAS) program. Researchers seek to determine if this supplement can improve recovery compared to conventional care. Participants in the intervention group will receive two servings of immunonutrition supplements daily for five days before surgery and continue for seven days after surgery alongside the ERAS protocol. The conventional group will follow the usual diet before surgery and receive a polymeric formula only if unable to consume 75% of their hospital diet postoperatively. During the study, participants' energy and protein intake, body composition, immunoglobulin levels, C-reactive protein, postoperative outcomes, functional status, and stress levels will be monitored for one month. The trial is randomized and open-label, with follow-up assessments to evaluate the impact of immunonutrition on recovery after surgery.
CONDITIONS
Perioperative Immunonutrition Under Enhanced Recovery After Surgery
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 days
Participants take immunonutrition supplements starting 5 days before surgery and continuing for 7 days after surgery as part of the Enhanced Recovery After Surgery protocol.
1 baseline visit before surgery and daily intake for 12 days
Duration - 1 month
Participants are monitored for postoperative outcomes and recovery for up to 1 month after surgery.
Approximately 4 weekly visits
Total: 1 location
1
Institut Kanser Negara
Putrajaya, Putrajaya, Malaysia, 62250
Actively Recruiting
C
ChiouYi Ho
Z
Zulfitri 'Azuan Mat Daud
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Linda Hertlein, Christine Zeder-Göß, Sophie Fürst...
https://pubmed.ncbi.nlm.nih.gov/29623417Aliza Abeles, Richard Mark Kwasnicki, Ara Darzi
https://pubmed.ncbi.nlm.nih.gov/28289508Jann Arends, Patrick Bachmann, Vickie Baracos...
https://pubmed.ncbi.nlm.nih.gov/27637832Chiou Yi Ho, Zuriati Ibrahim, Zalina Abu Zaid...
https://pubmed.ncbi.nlm.nih.gov/35011097Ho Chiou Yi, Zuriati Ibrahim, Zalina Abu Zaid...
https://pubmed.ncbi.nlm.nih.gov/31968595L A Mudge, D I Watson, B M Smithers...
https://pubmed.ncbi.nlm.nih.gov/29999517Laura Di Renzo, Antonino De Lorenzo, Marco Fontanari...
https://pubmed.ncbi.nlm.nih.gov/35353297Chiou Yi Ho, Zulfitri Azuan Mat Daud, Barakatun Nisak Mohd Yusof...
https://pubmed.ncbi.nlm.nih.gov/41842985ChiouYi Ho, Zulfitri Azuan Mat Daud, Barakatun Nisak Mohd Yusof...
https://pubmed.ncbi.nlm.nih.gov/39739975